Protein S Antigen, Free details
What Protein S Antigen, Free shows
Free Protein S measures the portion of Protein S — a natural anticoagulant protein — that circulates unbound and biologically active, as opposed to the portion bound to a carrier protein. Since the free fraction is the part that actually does the anticlotting work, this is often considered the more clinically useful measurement than total Protein S. Low free Protein S, whether from an inherited deficiency or acquired causes (like pregnancy, liver disease, or certain medications), raises the risk of abnormal blood clot formation, and it's typically tested as part of a broader clotting disorder workup after an unexplained blood clot.
Tests that include Protein S Antigen, Free
This profile helps to confirm and characterize congenital deficiency of protein S.
- Protein S Antigen, Free The unbound, biologically active portion of Protein S, a natural anticoagulant. Low levels raise the risk of blood clots.
- Protein S Antigen, Total Measures the total amount of Protein S — both free and bound forms — a natural anticoagulant. Low levels raise the risk of blood clots.
This profile helps to confirm and characterize congenital deficiency of protein S.
- Protein S Antigen, Free The unbound, biologically active portion of Protein S, a natural anticoagulant. Low levels raise the risk of blood clots.
- Protein S Antigen, Total Measures the total amount of Protein S — both free and bound forms — a natural anticoagulant. Low levels raise the risk of blood clots.
This profile helps to confirm and characterize congenital deficiency of protein S.
- Protein S Activity Measures the activity of Protein S, a natural anticoagulant that works with Protein C. Low activity raises the risk of blood clots.
- Protein S Antigen, Free The unbound, biologically active portion of Protein S, a natural anticoagulant. Low levels raise the risk of blood clots.
- Protein S Antigen, Total Measures the total amount of Protein S — both free and bound forms — a natural anticoagulant. Low levels raise the risk of blood clots.
This profile helps to confirm and characterize congenital deficiency of protein S.
- Protein S Activity Measures the activity of Protein S, a natural anticoagulant that works with Protein C. Low activity raises the risk of blood clots.
- Protein S Antigen, Free The unbound, biologically active portion of Protein S, a natural anticoagulant. Low levels raise the risk of blood clots.
- Protein S Antigen, Total Measures the total amount of Protein S — both free and bound forms — a natural anticoagulant. Low levels raise the risk of blood clots.
The Thrombotic Risk Assessment assesses an individual's risk for developing a thrombotic event, such as a stroke or heart attack, by measuring factors affecting blood clotting.
- Homocysteine An amino acid byproduct of protein metabolism. Elevated levels are linked to increased cardiovascular risk and can reflect low B vitamin (B12, folate, B6) status.
- Protein C Activity Measures the activity of Protein C, a natural anticoagulant. Low activity is linked to an increased risk of blood clots.
- Activated Protein C Resistance Checks whether your blood resists the natural anticlotting action of activated protein C, most often caused by the inherited factor V Leiden variant.
- Antithrombin III Activity Measures the activity of a protein that naturally helps prevent excessive blood clotting. Low levels are linked to an increased risk of blood clots.
- Beta-2-Glycoprotein I Antibody (IgA) Measures IgA antibodies against beta-2-glycoprotein I, one of the antiphospholipid antibodies, used to evaluate antiphospholipid syndrome and causes of blood clots.
- Beta-2-Glycoprotein I Antibody (IgG) Measures IgG antibodies against beta-2-glycoprotein I, one of the antiphospholipid antibodies, used to evaluate antiphospholipid syndrome and causes of blood clots.
- Beta-2-Glycoprotein I Antibody (IgM) Measures IgM antibodies against beta-2-glycoprotein I, one of the antiphospholipid antibodies, used to evaluate antiphospholipid syndrome and causes of blood clots.
- Cardiolipin Antibody (IgA) An antibody that attacks the body's own phospholipids (IgA type). One of the markers used to help diagnose antiphospholipid syndrome, which raises the risk of blood clots and pregnancy complications.
- Cardiolipin Antibody (IgG) An antibody that attacks the body's own phospholipids (IgG type). One of the markers used to help diagnose antiphospholipid syndrome, which raises the risk of blood clots and pregnancy complications.
- Cardiolipin Antibody (IgM) An antibody that attacks the body's own phospholipids (IgM type). One of the markers used to help diagnose antiphospholipid syndrome, which raises the risk of blood clots and pregnancy complications.
- Dilute Russell's Viper Venom Time (DRVVT) Screen A clotting test that helps screen for lupus anticoagulant, an antibody linked with a higher risk of blood clots and some pregnancy complications.
- Factor II (F2) DNA Analysis A genetic test for the prothrombin (Factor II) G20210A variant, an inherited change in the F2 gene that can raise the tendency to form blood clots.
- Lupus Anticoagulant Detects lupus anticoagulant, an antiphospholipid antibody that prolongs clotting tests in the lab but is linked to an increased risk of blood clots.
- Plasminogen Measures the activity of plasminogen, the protein that becomes plasmin to break down blood clots, used when assessing clotting and bleeding risk.
- Protein S Antigen, Free The unbound, biologically active portion of Protein S, a natural anticoagulant. Low levels raise the risk of blood clots.
- PTT-LA Screen A clotting-time screen sensitive to lupus anticoagulant, an antibody linked to blood clots, used as a first step in antiphospholipid testing.
Not sure how to read your results? We can help.
Schedule a consultation with a Hormunity specialist. We’ll walk through every marker, interpret what it means for you, and map out the next steps for your care.
Book a specialist